• About us
  • Contact us
  • Our team
  • Terms of Service
Wednesday, August 13, 2025
Kashmir Images - Latest News Update
Epaper
  • TOP NEWS
  • CITY & TOWNS
  • LOCAL
  • BUSINESS
  • NATION
  • WORLD
  • SPORTS
  • OPINION
    • EDITORIAL
    • ON HERITAGE
    • CREATIVE BEATS
    • INTERALIA
    • WIDE ANGLE
    • OTHER VIEW
    • ART SPACE
  • Photo Gallery
  • CARTOON
  • EPAPER
No Result
View All Result
Kashmir Images - Latest News Update
No Result
View All Result
Home NATION

3 lakh doses of intranasal Covid vaccine sent to hospitals: Bharat Biotech’s Krishna Ella

Press Trust of india by Press Trust of india
February 5, 2023
in NATION
A A
0
COVID-19 vaccination will be voluntary: Health ministry
FacebookTwitterWhatsapp

New Delhi: Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company’s executive chairman Krishna Ella said on Sunday.

He was speaking on the sidelines of an event here at which a bilateral agreement was signed between the University of Wisconsin (UW)-Madison Global Health Institute (GHI) and the Ella Foundation for the establishment of the first-ever UW-Madison One Health Centre in Bengaluru.

Related posts

Busting Exam Stress: Balancing Physical Health and Mental Well-being of Students

Cong, oppn protest well-thought-out strategy to create anarchy, instability in country: BJP

August 12, 2025
Parliament’s Monsoon session ends: Lok Sabha, Rajya Sabha adjourned sine die

Rajya Sabha sees heated exchanges between opposition and treasury benches over SIR

August 12, 2025

iNCOVACC, the world’s first intranasal COVID-19 vaccine, was launched on January 26. The vaccine is now available on CoWIN and priced at Rs 800 for private markets and Rs 325 for the government of India and state governments.

“We dispatched three lakh doses of the world’s first intranasal COVID-19 vaccine to some hospitals two days ago,” Ella said.

On whether Bharat Biotech is looking at exporting the vaccine, he said some countries and international agencies are approaching the company for the intra-nasal vaccine.

iNCOVACC is also the world’s first intranasal COVID-19 vaccine to receive approval for the primary 2-dose schedule, and as a heterologous booster dose for adults.

Ella said the UW-Madison One Health Centre in Bengaluru is expected to be operational by the end of 2023.

It will advance the development and production of new vaccines for India. Furthermore, the partnership will enable collaboration across disciplines and geographic boundaries, provide Indian students and researchers access to UW expertise and training, and build research capacity in India, he said.

“Both Ella Foundation and UW-Madison GHI share a common vision to advance innovation in science, research, and knowledge sharing. Establishing the UW-Madison Global One Health Centre holds great significance as it will advance global health through research, education, and community engagement by facilitating student, faculty exchanges, research and education,” he added.

UW-Madison GHI director Jorge Osorio said, “We are energised by the opportunity to partner with the Ella Foundation to bring UW knowledge and expertise to expand innovative and impactful health initiatives outside Wisconsin to India.”

The India One Health Centre joins a global network that includes Africa and Latin America and will open new opportunities for research, education, and provide actionable outcomes to benefit humans, animals, and ecosystems that advance equitable and sustainable health across India and the world.

Previous Post

India sees six-fold jump in voters since 1951; total electorate on Jan 1 is over 94.50 cr

Next Post

SC set to get five new judges on Monday

Press Trust of india

Press Trust of india

Next Post
SC to fix schedule of hearing of Ayodhya land dispute cases in January next year

SC set to get five new judges on Monday

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

ePaper

  • About us
  • Contact us
  • Our team
  • Terms of Service
E-Mailus: kashmirimages123@gmail.com

© 2024 Kashmir Images - Designed by GITS.

No Result
View All Result
  • TOP NEWS
  • CITY & TOWNS
  • LOCAL
  • BUSINESS
  • NATION
  • WORLD
  • SPORTS
  • OPINION
    • EDITORIAL
    • ON HERITAGE
    • CREATIVE BEATS
    • INTERALIA
    • WIDE ANGLE
    • OTHER VIEW
    • ART SPACE
  • Photo Gallery
  • CARTOON
  • EPAPER

© 2024 Kashmir Images - Designed by GITS.